Patent · US Active

Immunomodulatory compounds

US12234220B2 · kind B2 · utility

0Cited by

2References

42Claims

0Family size

Assignee

DANA-FARBER CANCER INSTITUTE, INC. · US

Inventors

Nathanael S. Gray · Boston, US
Tinghu Zhang · Brookline, US
Eric Fischer · East Sharon, US
Alyssa Verano · New York, US
Zhixiang He · Brookline, US
Guangyan Du · Brookline, US
Katherine Donovan · Boston, US
Radoslaw Nowak · Boston, US
Jing Yuan · Lansdale, US
Hu Liu · Beijing, CN

Key dates

Filing date	Jun 27, 2019
Grant date	Feb 25, 2025
Priority date	—
Expiry date	Feb 3, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4841
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are immunomodulatory compounds, pharmaceutical compositions containing them, and methods of making and using the compounds to treat diseases and disorders characterized by aberrant protein activity that can be targeted by cereblon.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.